|
English
|
正體中文
|
简体中文
|
2831143
|
|
???header.visitor??? :
33154196
???header.onlineuser??? :
1084
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"roy a c"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
國立成功大學 |
2013-06 |
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
|
Roy, A. C.; Park, S. R.; Cunningham, D.; Kang, Y. K.; Chao, Y.; Chen, L. T.; Rees, C.; Lim, H. Y.; Tabernero, J.; Ramos, F. J.; Kujundzic, M.; Cardic, M. B.; Yeh, C. G.; de Gramont, A. |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|